Cancer Urology

Онкоурология

1726-97761996-1812

Publishing House ABV Press

276

10.17650/1726-9776-2009-5-2-74

DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS

ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ

ЗАКЛЮЧИТЕЛЬНЫЙ МЕТААНАЛИЗ ИССЛЕДОВАНИЯ ЕРС (EARLY PROSTATE CANCER)

Редакционная

статья

Russian Federation

30062009

0408201404082014

https://oncourology.abvpress.ru/oncur/article/view/276

Заключительный метаанализ исследования ЕРС (Early Prostate Cancer)

1. http://clinicaltrials.gov/ct2/show/NCT 00657904?term=bicalutamide&rank=4

http://clinicaltrials.gov/ct2/show/NCT 00657904?term=bicalutamide&rank=4

2. See W.A., Wirth M.P., McLeod D.G. Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. J Urol 2002;168: 429—35.

See W.A., Wirth M.P., McLeod D.G. Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. J Urol 2002;168: 429—35.

3. Wirth M.P., See W.A, McLeod D.G. Bicalutamide 150 mg in addition to stan- dard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years. J Urol 2004;172: 1865—70.

Wirth M.P., See W.A, McLeod D.G. Bicalutamide 150 mg in addition to stan- dard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years. J Urol 2004;172: 1865—70.

4. Онкоурология, спецвыпуск 2006;(2):13. 5. McLeod D.G., Iversen P., See W.A. et al. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer. BJUI 2005;97:247—54.

Онкоурология, спецвыпуск 2006;(2):13. 5. McLeod D.G., Iversen P., See W.A. et al. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer. BJUI 2005;97:247—54.